You are here: Industry Insights > Molecular

News List

Novartis and Molecular Partners commence Covid-19 treatment trial pharmaceutical-technology
May 31, 2021
Novartis and Molecular Partners have commenced Phase II/III EMPATHY clinical trial of a new DARPin therapeutic candidate, ensovibep (MP0420), to treat Covid-19.
Novartis, Molecular Partners to develop two DARPin Therapies for COVID-19 americanpharmaceuticalreview
November 06, 2020
Novartis and Molecular Partners announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19 DARPin® program, consisting of two therapeutic candidates, MP0420 and MP04
Novartis and Molecular Partners collaborate on anti-Covid-19 programme pharmaceutical-technology
October 30, 2020
Novartis and Molecular Partners have entered into a collaboration in the form of an option and license agreement for the latter’s anti-COVID-19 DARPin programme.
Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics prnewswire
October 16, 2020
Aetion co-authored a study published in Science, which examined lethal coronaviruses SARS-CoV-2, SARS-CoV-1, and MERS-CoV to identify molecular characteristics of potential treatments.
IIT Guwahati and RIKEN-Japan collaborate for novel approach to separate chiral molecules expresspharma
August 27, 2020
The separation of enantiomers is important in the biomedical field because many biochemically active chemicals are found as mixtures of two enantiomers, one of which may be beneficial and the other, toxic.
AGC Biologics, Molecular Partners to Develop DARPin Anti-COVID-19 Program contractpharma
July 10, 2020
AGC Biologics will manufacture MP0420 at 100 liter and 1,000 liter scales for development and initial global supply.
Molecular Templates Announces Board of Directors Appointments americanpharmaceuticalreview
December 23, 2019
Molecular Templates announced the appointment of Corazon “Corsee” Dating Sanders, Ph.D. to its board of directors, effective immediately.
Phoenix Molecular, WuXi STA Reach Drug Supply Milestone contractpharma
June 10, 2019
Completes clinical trial supply to support Phase I/Ib study of PMD-026 for TNBC.
Silver nanoparticles improve molecular detection in Raman spectroscopy europeanpharmaceuticalreview
April 30, 2019
Researchers have improved molecular detection at low concentration levels by arranging nanoparticles on nanowires to enhance Raman spectroscopy….
Measuring molecular interactions using LiP-mass spectrometric analysis europeanpharmaceuticalreview
April 29, 2019
Researchers have systematically analysed and quantified the interactions of all proteins with metabolites on the level of the whole proteome…

Previous page 1 2 Next page